Literature DB >> 12077678

[Morphine and alternative opioids in cancer pain: the EAPC recommendations].

L Radbruch1, F Nauck.   

Abstract

An expert working group of the European Association for Palliative Care (EAPC) has revised and updated its guidelines on the use of morphine in the management of cancer pain. The revised recommendations presented here give guidance on the use of morphine and the alternative strong opioid analgesics which have been introduced in many parts of the world in recent years. Practical strategies for dealing with difficult situations are described presenting a consensus view where supporting evidence is lacking. The strength of the evidence on which each recommendation is based is indicated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077678     DOI: 10.1007/s004820100104

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  9 in total

1.  [Strong opioids and constipation].

Authors:  A Schwarzer; F Nauck; E Klaschik
Journal:  Schmerz       Date:  2005-06       Impact factor: 1.107

2.  [The right to pain treatment--obligatory continuing education].

Authors:  M Zenz
Journal:  Schmerz       Date:  2011-02       Impact factor: 1.107

Review 3.  Methadone as anticancer treatment: hype, hope, or hazard? : A series of case reports and a short review of the current literature and recommendations of the societies.

Authors:  Gudrun Kreye; Eva-Katharina Masel; Klaus Hackner; Beate Stich; Friedemann Nauck
Journal:  Wien Med Wochenschr       Date:  2018-02-19

4.  [Symptom management of pain and breathlessness].

Authors:  S T Simon; C Müller-Busch; C Bausewein
Journal:  Internist (Berl)       Date:  2011-01       Impact factor: 0.743

Review 5.  [Cancer pain therapy].

Authors:  F Nauck
Journal:  Urologe A       Date:  2009-10       Impact factor: 0.639

6.  [Oral transmucosal fentanyl citrate for the treatment of breakthrough pain. Results of a non-interventional study (NIS)].

Authors:  R Zarth; M Ehmer; H-B Sittig
Journal:  Schmerz       Date:  2007-11       Impact factor: 1.107

Review 7.  [Cancer pain management. Basic therapy and treatment of breakthrough pain].

Authors:  F Nauck; N Eulitz
Journal:  Schmerz       Date:  2007-08       Impact factor: 1.629

8.  Efficacy and safety of sustained-release oxycodone compared with immediate-release morphine for pain titration in cancer patients: A multicenter, open-label, randomized controlled trial (SOCIAL).

Authors:  Hongming Pan; Peng Shen; Qijin Shu; Liqin Lu; Suying Qian; Yuefen Zhou; Feng Han; Qunyi Guo; Zhiping Yang; Jie Pan; Qing Xu; Peng Zhang; Kaifeng Wang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

9.  Slow drug delivery decreased total body clearance and altered bioavailability of immediate- and controlled-release oxycodone formulations.

Authors:  Yan Li; Duxin Sun; Maria Palmisano; Simon Zhou
Journal:  Pharmacol Res Perspect       Date:  2016-01-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.